Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma
2018 ◽
Vol 9
(30)
◽
pp. 21022-21035
◽
Satoshi Ogura
◽
Yuichi Yoshida
◽
Tomohide Kurahashi
◽
Mayumi Egawa
◽
Kunimaro Furuta
◽
...
2007 ◽
Vol 16
(12)
◽
pp. 1023-1031
◽
A. Mukhopadhyay
◽
A. Khoo
◽
H. H. Cheong
◽
S. Y. Chan
◽
O. Aalami
◽
...
2012 ◽
Vol 13
(6)
◽
pp. 435-442
◽
Zhuhong Zhang
◽
Jing Yin
◽
Chunyan Zhang
◽
Ning Liang
◽
Nan Bai
◽
...
2000 ◽
Vol 2
(2)
◽
pp. 117-127
◽
S. Gagandeep
◽
Michael Ott
◽
Perry D. Nisen
◽
Ronald A. DePinho
◽
Sanjeev Gupta
2014 ◽
Vol 210
(8)
◽
pp. 477-481
◽
Li Xiaoyan
◽
Zang Shengbing
◽
Zhang Yu
◽
Zheng Lin
◽
Lin Chengjie
◽
...
2017 ◽
Vol 47
(11)
◽
pp. 1196-1205
◽
Mayumi Egawa
◽
Yuichi Yoshida
◽
Satoshi Ogura
◽
Tomohide Kurahashi
◽
Takashi Kizu
◽
...
1999 ◽
Vol 45
(3)
◽
pp. 299
S. Chung
◽
S.J. Advani
◽
J.D. Bradley
◽
Y. Kataoka
◽
B. Roizman
◽
...
2015 ◽
Vol 62
(4)
◽
pp. 1324-1324
◽
Nadia Panera
◽
Sara Ceccarelli
◽
Valerio Nobili
◽
Anna Alisi
2003 ◽
Vol 27
(4)
◽
pp. 289-301
◽
2015 ◽
Vol 93
◽
pp. n/a-n/a
◽
C. Yu-Wai-Man
◽
R. Treisman
◽
P.T. Khaw
◽
M. Bailly
2014 ◽
Vol 21
(3)
◽
pp. 133-138
◽
T Chen
◽
J Xiong
◽
C Yang
◽
L Shan
◽
G Tan
◽
...